Regional Disparities in COVID-19 Mortality Rates: An Analysis of the 2021 National Inpatient Sample

Amid the 2019 coronavirus (COVID-19) pandemic, regional disparities in outcomes were identified as crucial for an effective public health response. Regional variations in COVID-19 outcomes in the United States of America (USA) were studied in this retrospective cross-sectional analysis, with a focus on in-hospital mortality rates among COVID-19 patients with pneumonia or respiratory failure, using the 2021 National Inpatient Sample dataset. Patients aged ≥18 years with confirmed diagnoses of COVID-19 associated pneumonia or respiratory failure were included in the study. The association between hospital census regions and in-hospital mortality rates was examined using multivariate logistic regression, adjusting for demographic, clinical, and hospital characteristics. Significant disparities in regional COVID-19 outcomes in the USA were revealed by the results. Mortality rates in the COVID-19 study cohort ranged from 14% in the Midwest to 18% in the West. Adjusted significant differences were shown by regression analysis, with the West exhibiting up to 28% higher odds of death (odds ratio: 1.28, 95% confidence interval: 1.218–1.354, p<0.001) than the Midwest, the region with the lowest mortality. The importance of accounting for demographic, clinical, and contextual factors in understanding these disparities and addressing regional disparities to promote health equity during the ongoing pandemic was underscored by these substantial regional variations in COVID-19 mortality rates in the USA.